You are here

Aslan Pharma raises US$34m in fresh funding

Temasek Holdings.jpg
A man walks pass the Temasek Holdings office on Feb 16, 2015.


THE Republic's fledgling pharma ecosystem on Monday got a shot in the arm as biotech startup Aslan Pharmaceuticals announced it has raised US$34 million in Series C funding led by Accuron Technologies, a tech subsidiary of Temasek Holdings.

The proceeds, said Aslan, will

Market voices on:


Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at

Powered by GET.comGetCom